Try our beta test site
Trial record 1 of 1 for:    NCT01835223
Previous Study | Return to List | Next Study

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Comprehensive Cancer Network
AVEO Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01835223
First received: April 15, 2013
Last updated: February 22, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 14, 2018
  Estimated Primary Completion Date: August 14, 2017 (Final data collection date for primary outcome measure)